These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 8142504

  • 1. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC, Martínez-Grueiro MM, Martínez-Fernández AR.
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [Abstract] [Full Text] [Related]

  • 2. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F.
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [Abstract] [Full Text] [Related]

  • 3. Azithromycin prophylaxis and treatment of murine toxoplasmosis.
    Tabbara KF, Hammouda E, Tawfik A, Al-Omar OM, Abu El-Asrar AM.
    Saudi Med J; 2005 Mar; 26(3):393-7. PubMed ID: 15806206
    [Abstract] [Full Text] [Related]

  • 4. Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae).
    Costa IN, Angeloni MB, Santana LA, Barbosa BF, Silva MC, Rodrigues AA, Rostkowsa C, Magalhães PM, Pena JD, Silva DA, Mineo JR, Ferro EA.
    Placenta; 2009 Oct; 30(10):884-90. PubMed ID: 19703714
    [Abstract] [Full Text] [Related]

  • 5. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS, de Souza W, Vommaro RC.
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [Abstract] [Full Text] [Related]

  • 6. Nifurtimox plus pyrimethamine for treatment of murine toxoplasmosis.
    Aguirre-Cruz L, Velasco O, Sotelo J.
    J Parasitol; 1998 Oct; 84(5):1032-3. PubMed ID: 9794648
    [Abstract] [Full Text] [Related]

  • 7. [In vitro effect of combined traditional Chinese medicine (Changqing capsule) on the tachyzoites of Toxoplasma gondii].
    Zhang W, Fang FR, Liu YJ, Yang LD, Luo RY, Gong F, Lu H, Xu XX.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb 28; 24(1):56-8. PubMed ID: 16866146
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the mood-stabilizing agent valproic acid as a preventative for toxoplasmosis in mice and activity against tissue cysts in mice.
    Goodwin DG, Strobl J, Mitchell SM, Zajac AM, Lindsay DS.
    J Parasitol; 2008 Apr 28; 94(2):555-7. PubMed ID: 18564764
    [Abstract] [Full Text] [Related]

  • 11. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S, Bryskier A, Moutot M, Derouin F.
    J Antimicrob Chemother; 1995 Jun 28; 35(6):821-32. PubMed ID: 7559193
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of ponazuril in vitro and in preventing and treating Toxoplasma gondii infections in mice.
    Mitchell SM, Zajac AM, Davis WL, Lindsay DS.
    J Parasitol; 2004 Jun 28; 90(3):639-42. PubMed ID: 15270113
    [Abstract] [Full Text] [Related]

  • 13. Lack of therapeutic effect of colchicine on murine toxoplasmosis.
    Aguirre-Cruz L, Sotelo J.
    J Parasitol; 1998 Feb 28; 84(1):163-4. PubMed ID: 9488356
    [Abstract] [Full Text] [Related]

  • 14. Buprenorphine does not affect acute murine toxoplasmosis and is recommended as an analgesic in Toxoplasma gondii studies in mice.
    Lindsay DS, Kaur T, Mitchell SM, Goodwin DG, Strobl J, Dubey JP.
    J Parasitol; 2005 Dec 28; 91(6):1488-90. PubMed ID: 16544426
    [Abstract] [Full Text] [Related]

  • 15. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E.
    Parassitologia; 2004 Jun 28; 46(1-2):89-93. PubMed ID: 15305694
    [Abstract] [Full Text] [Related]

  • 16. Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models.
    Barbosa BF, Gomes AO, Ferro EA, Napolitano DR, Mineo JR, Silva NM.
    Vet Parasitol; 2012 Jun 08; 187(1-2):44-52. PubMed ID: 22281151
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J, Djurković-Djaković O, Nikolić A, Klun I, Bobić B.
    Int J Antimicrob Agents; 2005 Mar 08; 25(3):226-30. PubMed ID: 15737517
    [Abstract] [Full Text] [Related]

  • 18. Toxoplasma gondii: effects of Artemisia annua L. on susceptibility to infection in experimental models in vitro and in vivo.
    de Oliveira TC, Silva DA, Rostkowska C, Béla SR, Ferro EA, Magalhães PM, Mineo JR.
    Exp Parasitol; 2009 Jul 08; 122(3):233-41. PubMed ID: 19389400
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of immunization with tachyzoite excreted-secreted proteins in a novel susceptible mouse model (A/Sn) for Toxoplasma gondii.
    Costa-Silva TA, Meira CS, Ferreira IM, Hiramoto RM, Pereira-Chioccola VL.
    Exp Parasitol; 2008 Nov 08; 120(3):227-34. PubMed ID: 18706414
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.